NDC 17772-102 Trokendi Xr
Topiramate Capsule, Extended Release Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 17772 - Supernus Pharmaceuticals
- 17772-102 - Trokendi Xr
Product Characteristics
YELLOW (C48330)
ORANGE (C48331)
22 MM
SPN;50
Product Packages
NDC Code 17772-102-01
Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Price per Unit: $15.36394 per EA
NDC Code 17772-102-07
Package Description: 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
NDC Code 17772-102-10
Package Description: 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
NDC Code 17772-102-12
Package Description: 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
NDC Code 17772-102-30
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Price per Unit: $15.36394 per EA
Product Details
What is NDC 17772-102?
What are the uses for Trokendi Xr?
What are Trokendi Xr Active Ingredients?
- TOPIRAMATE 50 mg/1 - A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.
Which are Trokendi Xr UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOPIRAMATE (UNII: 0H73WJJ391)
- TOPIRAMATE (UNII: 0H73WJJ391) (Active Moiety)
Which are Trokendi Xr Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MANNITOL (UNII: 3OWL53L36A)
- DOCUSATE SODIUM/SODIUM BENZOATE (UNII: 656HXR6YXN)
- ETHYLCELLULOSE, UNSPECIFIED (UNII: 7Z8S9VYZ4B)
- OLEIC ACID (UNII: 2UMI9U37CP)
- MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TALC (UNII: 7SEV7J4R1U)
- XANTHAN GUM (UNII: TTV12P4NEE)
- GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- RIBOFLAVIN (UNII: TLM2976OFR)
- GLYCERIN (UNII: PDC6A3C0OX)
- LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
- SHELLAC (UNII: 46N107B71O)
- HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- FD&C RED NO. 3 (UNII: PN2ZH5LOQY)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for Trokendi Xr?
- RxCUI: 1436239 - topiramate 50 MG 24HR Extended Release Oral Capsule
- RxCUI: 1436239 - 24 HR topiramate 50 MG Extended Release Oral Capsule
- RxCUI: 1436239 - topiramate 50 MG 24 HR Extended Release Oral Capsule
- RxCUI: 1436245 - Trokendi 50 MG 24HR Extended Release Oral Capsule
- RxCUI: 1436245 - 24 HR topiramate 50 MG Extended Release Oral Capsule [Trokendi]
Which are the Pharmacologic Classes for Trokendi Xr?
* Please review the disclaimer below.
Patient Education
Topiramate
Topiramate is used alone or with other medications to treat certain types of seizures including primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) and partial onset seizures (seizures that involve only one part of the brain). Topiramate is also used with other medications to control seizures in people who have Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). Topiramate is also used to prevent migraine headaches but not to relieve the pain of migraine headaches when they occur. Topiramate is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".